期刊文献+

贵州省112所医院医院感染质量控制指标调查分析 被引量:5

Data analysis related to healthcare-associated infections of 112 hospitals in province Guizhou in 2012
原文传递
导出
摘要 目的通过对贵州省112所医院感染控制监测数据收集和分析,了解贵州省及各地州市医院感染基本情况与发生特点,为制定医院感染预防与控制措施提供参考。方法 2012年1月1日-9月30日对112所贵州省各地州市二级以上医院的感染率、抗菌药物使用、手术部位感染及重点部位感染相关数据进行统计分析,各医院通过邮件、传真形式上传数据至省质量控制中心,由质量控制中心审核数据后,录入、分析。结果共112所医院参与调查,106所医院参与感染率调查,占94.64%;共调查医院患者4 4 771例,发生医院感染1 279例、1 349例次,感染率2.84%、例次感染率3.21%;37 128例住院患者抗菌药物使用、预防用药、治疗用药的平均使用率分别为44.54%、28.91%、71.09%,病原菌送检率19.41%;调查手术患者58 598例,术后发生切口感染670例,感染率为1.14%,肺部感染156例感染率为0.27%。结论通过对贵州省各级医院横断面调查,掌握医院感染变化趋势,提示各医疗机构应进一步规范医院感染病例监测,加强抗菌药物合理使用,提高病原菌送检率,减少耐药菌发生,认真落实重点部位感染预防相关指南,以降低侵入性操作的感染率。 OBJECTIVE To evaluate the basic situations and prevalence of healthcare-associated infections(HAIs)in 112 hospitals in Guizhou province,so as to provide basis for making policy for preventing and controlling HAIs.METHODS Data from prevalence survey,antimicrobial agents′usage,surgical site infection and the key site infection of second class and upwards general hospitals during Jan.1st to Sep.30 th of 2012 were collected and analyzed.Every hospital uploaded their data to the province quality control center by email,fax,then after checking the data the center input and analyzed the data.RESULTS Among 112 hospitals,106joined the prevalence survey,accounting for 94.64%.A total of 44,771 patients were surveyed,among which 1279 cases with hospital infections,1349 case times with the infection rate of 2.84% and case times infection rate 3.21%.The rates of antimicrobial drug use,prophylactic use,treatment drug use were 44.54%,28.91%and 71.08%.Rate of pathogenic bacteria was 19.41%.Postoperative wound infection rate and lung infection rate was 1.14%(670cases)and 0.27%(156)respectively in 58,598 patients.CONCLUSION We further recognized the trend of changing about HAIs through analyzing prevalence survey and relative data across the whole province,which suggested the monitoring methods of HAIs should be further standardized in each hospital.To increase the examination rate is necessary for decreasing the generating more resistant bacteria.Results also suggested hospitals should strictly perform relative guides for infection preventing at invasive parts in purpose of decreasing the infection rate.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2014年第19期4890-4892,共3页 Chinese Journal of Nosocomiology
基金 贵州省科技厅科研基金资助项目(黔科合J字[2011]2153)
关键词 医院感染 监测数据 预防与控制 Healthcare-associated infection Surveillance data Prevention and control
  • 引文网络
  • 相关文献

参考文献8

二级参考文献80

  • 1吴安华,任南,文细毛,易霞云,黄勋,徐秀华.159所医院医院感染现患率调查结果与分析[J].中国感染控制杂志,2005,4(1):12-16. 被引量:202
  • 2XIONG Zi-zhong ZHU De-mei WANG Fu ZHANG Ying-yuan.CTX-M-14, CTX-M-24 and resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates[J].Chinese Medical Journal,2006(2):160-164. 被引量:13
  • 3任南,文细毛,吴安华.全国医院感染横断面调查结果的变化趋势研究[J].中国感染控制杂志,2007,6(1):16-18. 被引量:352
  • 4中华人民共和国卫生部,医院感染诊断标准[s].北京:中华人民共和国卫生部,2001.
  • 5Lee J, Pai H, Kim YK, et al. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy[J]. J Antimicrob Chemother, 2007,60 (3): 629- 637.
  • 6Chang S, Sethi AK, Eckstein BC, et al. Skin and environmental contamination with methicillin-resistant Staphylococcus aureus among carriers identified clinically versus through active surveillase[J]. Clin Infect Dis, 2009,48 (10): 1423-8.
  • 7Eckstein PC, Adams DA, Eckstein EC, et al. Reduction of Clostridium Difficile and vaneomydn-resistant Enteroeoccus contamina fion of environmental surfaces after an intervention to improve cleaning methods[J]. BMC Infect Dis,2007, 7(1):61.
  • 8Weber DJ,Rutala WA,Miller MB,et al. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: Norovirus, Clostridium difficile, and Acinetobacter species[J]. Am J Infect Control, 2010,38 (5 Suppl 1) : S25- S33.
  • 9Bearman GM,Marra AR,Sessler CN,et al. A controlled trial of universal gloving versus contact precautions for preventing the transmission of multidrug-resistant organisms[J]. Am J Infect Control, 2007,35 (10): 650-655.
  • 10Devasahayam G, Scheld WM, Hoffman PS. Newer antibacterial drugs for a new century[J]. Expert Optin invest Drugs, 2010;19: 215.

共引文献638

同被引文献51

引证文献5

二级引证文献64

;
使用帮助 返回顶部